AGNC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AGNC Investment Corp is not a strong buy at the moment for a beginner investor seeking long-term growth. While the stock offers a high dividend yield and has shown strong financial performance in the latest quarter, the technical indicators suggest a bearish trend, and the options data reflects a lack of bullish sentiment. Additionally, analyst ratings are mixed, with some downgrades citing valuation concerns. Given the investor's preference for long-term stability, it may be better to wait for a more favorable entry point or consider alternative investments with lower risk profiles.
The MACD is negative and expanding, indicating a bearish momentum. RSI is at 19.022, signaling the stock is oversold. Moving averages are converging, showing indecision in the trend. The stock is trading near its key support level of 10.9, with resistance at 11.187. Overall, the technical indicators suggest a bearish trend.
AGNC offers a high monthly dividend yield of 12.8%, which is attractive for income-seeking investors.
The company reported strong financial growth in Q4 2025, with revenue up 93.63% YoY and net income up 955.81% YoY.
Analysts have issued mixed ratings, with some downgrades citing valuation concerns and limited upside potential.
The stock is trading at a significant premium to its book value, which may limit future growth.
Technical indicators point to a bearish trend, with the stock being oversold and MACD showing negative momentum.
In Q4 2025, AGNC reported a 93.63% YoY increase in revenue, a 955.81% YoY increase in net income, and a 730% YoY increase in EPS. Gross margin improved significantly to 57.41%, up 233.59% YoY. These results indicate strong financial growth and operational efficiency.
Analyst ratings are mixed. RBC Capital and Wells Fargo raised price targets and maintained positive ratings, citing strong economic returns and favorable macro conditions. However, firms like Keefe Bruyette and JonesResearch downgraded the stock due to valuation concerns and a balanced risk-reward profile. The consensus price target ranges from $11.50 to $13, suggesting limited upside from the current price.
